Looking for better ways to track beta cell decline in people with type 1 diabetes – COMPLETED

Mark Peakman
Mark Peakman

Scientific title: Immunological markers of beta cell decline in new onset type 1 diabetes
Principal Investigator: Professor Mark Peakman
Institution: King’s College London
Project duration: 01/07/2014 – 30/06/2017

Objective: The aim of this project is to search for consistent, identifiable markers in the blood of people with type 1, and to link these to measurements of their immune system – for example, its response to beta cells. This would provide a more efficient way to predict the rate of beta cell decline, rather than relying on indirect measures such as insulin requirements.

The research will use data from the JDRF-funded TrialNet database, among others.

Categories: Cure, Strategic Research Agreement, Immune Therapies